Literature DB >> 35614909

Bacterial endotoxins and exotoxins in intensive care medicine.

J R Sheehan1, C Sadlier1, B O'Brien1.   

Abstract

Entities:  

Keywords:  endotoxins; exotoxins; sepsis

Year:  2022        PMID： 35614909      PMCID： PMC9125418          DOI： 10.1016/j.bjae.2022.01.003

Source DB:  PubMed          Journal:  BJA Educ        ISSN： 2058-5349


× No keyword cloud information.
  13 in total

Review 1.  Tetanus.

Authors:  Lam Minh Yen; C Louise Thwaites
Journal:  Lancet       Date:  2019-03-29       Impact factor: 79.321

Review 2.  Gram-positive toxic shock syndromes.

Authors:  Emma Lappin; Andrew J Ferguson
Journal:  Lancet Infect Dis       Date:  2009-05       Impact factor: 25.071

3.  Assessment of Clinical Criteria for Sepsis: For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Christopher W Seymour; Vincent X Liu; Theodore J Iwashyna; Frank M Brunkhorst; Thomas D Rea; André Scherag; Gordon Rubenfeld; Jeremy M Kahn; Manu Shankar-Hari; Mervyn Singer; Clifford S Deutschman; Gabriel J Escobar; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

Review 4.  Botulinum toxin.

Authors:  B Zane Horowitz
Journal:  Crit Care Clin       Date:  2005-10       Impact factor: 3.598

Review 5.  Bacterial lipopolysaccharides and innate immunity.

Authors:  C Alexander; E T Rietschel
Journal:  J Endotoxin Res       Date:  2001

Review 6.  Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shock.

Authors:  Marissa M Alejandria; Mary Ann D Lansang; Leonila F Dans; Jacinto Blas Mantaring
Journal:  Cochrane Database Syst Rev       Date:  2013-09-16

7.  Treatment of septic shock with human monoclonal antibody HA-1A. A randomized, double-blind, placebo-controlled trial. CHESS Trial Study Group.

Authors:  R V McCloskey; R C Straube; C Sanders; S M Smith; C R Smith
Journal:  Ann Intern Med       Date:  1994-07-01       Impact factor: 25.391

8.  Effect of Targeted Polymyxin B Hemoperfusion on 28-Day Mortality in Patients With Septic Shock and Elevated Endotoxin Level: The EUPHRATES Randomized Clinical Trial.

Authors:  R Phillip Dellinger; Sean M Bagshaw; Massimo Antonelli; Debra M Foster; David J Klein; John C Marshall; Paul M Palevsky; Lawrence S Weisberg; Christa A Schorr; Stephen Trzeciak; Paul M Walker
Journal:  JAMA       Date:  2018-10-09       Impact factor: 56.272

9.  Effects of Polymyxin B Hemoperfusion on Mortality in Patients With Severe Sepsis and Septic Shock: A Systemic Review, Meta-Analysis Update, and Disease Severity Subgroup Meta-Analysis.

Authors:  Tzu Chang; Yu-Kang Tu; Chen-Tse Lee; Anne Chao; Chi-Hsiang Huang; Ming-Jiuh Wang; Yu-Chang Yeh
Journal:  Crit Care Med       Date:  2017-08       Impact factor: 7.598

10.  Polyspecific Intravenous Immunoglobulin in Clindamycin-treated Patients With Streptococcal Toxic Shock Syndrome: A Systematic Review and Meta-analysis.

Authors:  Tom Parks; Clare Wilson; Nigel Curtis; Anna Norrby-Teglund; Shiranee Sriskandan
Journal:  Clin Infect Dis       Date:  2018-10-15       Impact factor: 9.079
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.